Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Personalized rTMS therapy to improve walking in Parkinson's patients

Official title: Safety and Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Ambulatory Function in Patients With Parkinson Disease

Run by Samsung Medical Center · NCT06350617 · Data updated 2026-11-12

This study is testing whether personalized brain stimulation can help improve walking in people with Parkinson's disease better than standard treatments.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment60 (estimated)
SponsorSamsung Medical Center
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedFebruary 20, 2024
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedApril 28, 2026
Trial IDNCT06350617 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 50 and older with Parkinson's disease who can walk without assistance and are in stages 2 to 4 of the Modified Hoehn and Yahr scale.

Probably not a fit

Patients with significant cognitive impairment or other neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of personalized repetitive transcranial magnetic stimulation (rTMS) protocols tailored to the functional reserve of patients with Parkinson's disease. By categorizing patients based on their motor and cognitive functional reserves, the study aims to compare the efficacy of these personalized protocols against conventional high-frequency rTMS applied to the primary motor cortex. The approach seeks to enhance motor function recovery by addressing the unique needs of each patient rather than using a one-size-fits-all method. Participants will be randomly assigned to different treatment groups to evaluate the outcomes of this tailored therapy.

Why it matters

Potential benefit: If successful, this study could lead to more effective treatments for improving mobility in patients with Parkinson's disease.

How similar studies have gone: While traditional rTMS has been widely studied, this personalized approach based on functional reserve is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. patients with Parkinson's disease, diagnosed by the United Kingdom (UK) Parkinson's Disease Society Brain Bank Diagnostic Criteria,
2. Modified Hoehn and Yahr (H\&Y) scale, stage 2\~4,
3. patients who can walk on flat surfaces without the need for a gait aid,
4. aged ≥50 years old,
5. patients willing to sign the informed consent.

Exclusion Criteria:

1. those with contraindications to rTMS, such as epilepsy, implanted metal objects in the head, or a history of craniotomy,
2. those with cognitive impairment, confirmed through the Montreal Cognitive Assessment (MoCA) test as follows: \< 7 points: Illiterate \< 13 points: Education duration 0.5-3 years \< 16 points: Education duration 4-6 years \< 19 points: Education duration 7-9 years \< 20 points: Education duration 10 years or more
3. those with coexisting neurological conditions, such as spinal cord injury or Stroke,
4. those with major psychiatric disorders, such as major depression, schizophrenia, or dementia,
5. those with severe on-off phenomena or severe dyskinesia, deemed by the investigators to render participation in the study inappropriate.
6. those having contraindications to conduct an MRI study,
7. those who are pregnant or lactating,
8. patients who have refused to participate in this study.

Where it's running

  • Samsung Medical Center
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.